CVS Health said on November 20, 2025 its Board of Directors appointed J. David Joyner, President and Chief Executive Officer, to the additional role of Chair of the Board, effective January 1, 2026.

1. 01

   CVS Health said on November 20, 2025 its Board of Directors appointed J. David Joyner, President and Chief Executive Officer, to the additional role of Chair of the Board, effective January 1, 2026.

2. 02

   The company said that following the effective date of this appointment, Michael F. Mahoney will continue to serve as the Board's Lead Independent Director, and Roger N. Farah, who is currently serving as Executive Chair of the Board, will continue to serve on the Board.

3. 03

   CVS Health said Joyner was named President and Chief Executive Officer in October 2024, and the Board determined he should also serve as Chair of the Board in recognition of his leadership, approximately 40 years of experience in the health care industry, and the Company's future growth opportunities.

4. 04

   The company said Roger Farah explained that the Board determined a structure with one leader having deep industry experience in the combined Chair and Chief Executive Officer roles will provide the best opportunity to execute on the long-term strategy and create stockholder value.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.